ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 141 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 2.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $126,000 | -6.0% | 11,002 | +0.6% | 0.00% | – |
| Q3 2017 | $134,000 | +3.1% | 10,936 | -3.6% | 0.00% | – |
| Q2 2017 | $130,000 | -65.6% | 11,342 | -37.6% | 0.00% | -100.0% |
| Q1 2017 | $378,000 | +6.2% | 18,189 | +6.3% | 0.00% | 0.0% |
| Q4 2016 | $356,000 | -36.4% | 17,113 | +0.1% | 0.00% | -50.0% |
| Q3 2016 | $560,000 | +54.3% | 17,088 | +17.7% | 0.00% | +100.0% |
| Q2 2016 | $363,000 | +28.3% | 14,520 | +25.6% | 0.00% | 0.0% |
| Q1 2016 | $283,000 | -27.4% | 11,564 | -2.0% | 0.00% | 0.0% |
| Q4 2015 | $390,000 | +4.3% | 11,801 | +3.5% | 0.00% | -50.0% |
| Q3 2015 | $374,000 | – | 11,403 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 2,942,130 | $40,160,000 | 10.45% |
| Foresite Capital Management II, LLC | 1,586,220 | $21,652,000 | 9.78% |
| DAFNA Capital Management LLC | 571,013 | $7,794,000 | 3.36% |
| Redmile Group, LLC | 8,244,896 | $112,543,000 | 3.29% |
| Lion Point Capital, LP | 1,271,500 | $17,355,000 | 1.57% |
| Palo Alto Investors LP | 1,861,630 | $25,411,000 | 1.06% |
| SAMLYN CAPITAL, LLC | 3,185,983 | $43,488,000 | 1.03% |
| Bellevue Group AG | 1,286,748 | $17,564,000 | 0.97% |
| BB BIOTECH AG | 2,766,008 | $37,756,000 | 0.95% |
| Rock Springs Capital Management LP | 1,560,000 | $21,294,000 | 0.82% |